Cost-effectiveness analysis of sarcopenia management interventions in Iran

Cost-effectiveness analysis of sarcopenia management interventions in Iran

Abstract Objectives Identification the optimal management intervention of sarcopenia is a concern of health systems. We aimed to analyze the cost-effectiveness of sarcopenia management strategies in Iran. Methods We constructed a lifetime Markov model based on natural history. The strategies compare...

Full description

Bibliographic Details
Main Authors:	Ali Darvishi, Gita Shafiee, Narges Zargar Balajam, Mohsen Rezaei Hemami, Navid Ostovar, Ramin Heshmat
Format:	Article
Language:	English
Published:	BMC 2023-05-01
Series:	BMC Public Health
Subjects:	Sarcopenia Management intervention Economic evaluation Cost-Utility Analysis (CUA) Quality-adjusted life years (QALYs)
Online Access:	https://doi.org/10.1186/s12889-023-15693-w

Similar Items

Sarcopenia screening strategies in older people: a cost effectiveness analysis in Iran
by: Ali Darvishi, et al.
Published: (2021-05-01)

Considering the societal perspective in economic evaluations: a systematic review in the case of depression
by: Juliane Andrea Duevel, et al.
Published: (2020-09-01)

Ethical considerations in sarcopenia research
by: Gita Shafiee, et al.
Published: (2023-12-01)

Cost-Utility Analysis of Rosuvastatin (20 mg) to Prevent Cardiovascular Diseases in Iran
by: Aziz Rezapour, et al.
Published: (2024-07-01)

The effect of Sarcomeal® oral supplementation plus vitamin D3 on muscle parameters and metabolic factors in diabetic sarcopenia patients: study protocol of a randomized controlled clinical trial
by: Ramin Abdi Dezfouli, et al.
Published: (2024-12-01)

Economic burden of sarcopenia-related disability in the elderly population: a study in Iran
by: Ali Darvishi, et al.
Published: (2024-10-01)

Economic Evaluation of Coronary Heart Disease (CHD): Expectations and Challenges in UK and Iran
by: AD Parsa, et al.
Published: (2005-03-01)

Cost-effectiveness of oral versus injectable disease modifying therapies in relapsing multiple sclerosis: a systematic review analysis
by: Mehdi Rezaee, et al.
Published: (2024-10-01)

Pharmacoeconomic analysis of the use of tocilizumab in therapy for rheumatoid arthritis:imitation simulation
by: Dmitry Vladimirovich Goryachev, et al.
Published: (2010-04-01)

Economic Evaluation of Coronary Heart Disease (CHD): Expectations and Challenges in UK and Iran
by: AD Parsa, et al.
Published: (2005-10-01)

THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES
by: N. Z. Musina, et al.
Published: (2017-05-01)

Markov Models for Economic Evaluation in Osteoporosis Treatment
by: Marta Osca-Guadalajara, et al.
Published: (2021-09-01)

The application of the QALY measure in the assessment of the effects of health interventions on an older population: a systematic scoping review
by: Ewa Kocot, et al.
Published: (2021-11-01)

Quality of life and growth hormone deficiency in adult patients in clinical evaluation and health economic assessment
by: Maria Kołtowska-Häggström
Published: (2009-09-01)

Extracorporeal carbon dioxide removal compared to ventilation alone in patients with acute hypoxaemic respiratory failure: cost-utility analysis of the REST RCT
by: Agus Ashley, et al.
Published: (2023-08-01)

Relationship Between Sarcopenia and Electrocardiographic Abnormalities in Older People: The Bushehr Elderly Health Program
by: Ramin Heshmat, et al.
Published: (2021-05-01)

The integrated care pathway for managing post stroke patients (iCaPPS©) in public primary care Healthcentres in Malaysia: impact on quality adjusted life years (QALYs) and cost effectiveness analysis
by: Aznida Firzah Abdul Aziz, et al.
Published: (2020-02-01)

Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions
by: Federico Augustovski, et al.
Published: (2018-02-01)

Cost–Utility Analysis of Wide-Field Imaging as an Auxiliary Technology for Retinopathy of Prematurity Care in Brazil
by: Luiza M Neves, et al.
Published: (2021-12-01)

Development of a Simple and Practical Screening Tool for Detection of Sarcopenia in Older People: The Bushehr Elderly Health Program
by: Gita Shafiee, et al.
Published: (2021-04-01)

Cost-utility analysis comparing laparoscopic vs open aortobifemoral bypass surgery
by: Krog AH, et al.
Published: (2017-06-01)

Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy
by: Shalin Rawal, et al.
Published: (2022-06-01)

Socioeconomic inequalities in type 2 diabetes mellitus: a study based on a population-based survey in Iran
by: Ali Darvishi, et al.
Published: (2024-03-01)

Consideration of the Medical Economics of Cardiac Genetics, Focusing on the Cost-Effectiveness of P2Y12 Inhibitor Selection Based on the <i>CYP2C19</i> Loss-of-Function Allele: A Semi-Systematic Review
by: Tomoyuki Takura
Published: (2024-04-01)

Characteristics of health-state utilities used in cost-effectiveness analyses: a systematic review of published studies in Asia
by: Zhihao Yang, et al.
Published: (2023-06-01)

Cost-utility analysis in chronic kidney disease patients undergoing kidney transplant; what pays? A systematic review
by: Sameera Senanayake, et al.
Published: (2020-05-01)

Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF
by: F. S. Mennini, et al.
Published: (2018-07-01)

The role and impact of health economics in the optimization of patient care in osteoarthritis: insights from a practical example
by: Mickaël Hiligsmann, et al.
Published: (2024-04-01)

Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system
by: T. S. Teptsova, et al.
Published: (2021-02-01)

Yet another Ersatz World: The ICER Final Evidence Report for Additive Cardiovascular Therapies
by: Paul Langley
Published: (2019-12-01)

Peritoneal dialysis vs. hemodialysis among patients with end-stage renal disease in Iran: which is more cost-effective?
by: Mahmood Yousefi, et al.
Published: (2024-03-01)

Identification of candidate genes and proteins in aging skeletal muscle (sarcopenia) using gene expression and structural analysis
by: Gita Shafiee, et al.
Published: (2018-09-01)

Three‐year cost utility analysis of mini versus standard slings: A trial based economic evaluation
by: Mary Kilonzo, et al.
Published: (2024-02-01)

Cost-utility analysis of total knee arthroplasty for osteoarthritis in a regional medical center in China
by: Qi Gui, et al.
Published: (2019-05-01)

Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran
by: Satar Rezaei, et al.
Published: (2024-11-01)

Cost-Effectiveness Analyses of Home Parenteral Nutrition for Incurable Gastrointestinal Cancer Patients
by: Wenqian Li, et al.
Published: (2022-05-01)

Cooled radiofrequency ablation of the genicular nerves for chronic pain due to osteoarthritis of the knee: a cost-effectiveness analysis compared with intra-articular hyaluronan injections based on trial data
by: Mehul J. Desai, et al.
Published: (2022-05-01)

Deceased donor kidney allocation: an economic evaluation of contemporary longevity matching practices
by: Sameera Senanayake, et al.
Published: (2020-10-01)

A missing cornerstone in the Norwegian Priority Commission’s weighting scheme – Sub-treatment balancedness is a necessary property for priority setting criteria
by: Mathias Barra, et al.
Published: (2016-08-01)

The Great I-QALY Disaster
by: Paul Langley
Published: (2020-08-01)